...
首页> 外文期刊>International journal of clinical pharmacy. >Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis
【24h】

Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis

机译:Ivabradine对鼻窦狭窄患者Ivabradine对β-嵌障人员的比较疗效:系统审查和荟萃分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Patients with mitral valve stenosis have increased heart rate. HR reduction is known as an important treatment and therapy strategy for patients with mitral valve stenosis. Aim of the review The aim of this systematic review and meta-analysis was to compare the efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm. Methods Randomized controlled trials were searched in Cochrane Library, PubMed, Web of Science, CRD, Scopus, and Google Scholar with no start time limitation and ending June 2018. Risk of bias across was assessed by the Cochrane Risk of Bias Assessment tool. Fixed effects models were used to combine the results and the mean difference with a 95% confidence interval. This meta-analysis was performed using Meta Package in R software. Results Five studies entered meta-analysis. The total number of patients treated with ivabradine and beta-blockers was 178 and 178 respectively. The results showed that the mean of maximum HR and HR at rest was lower at about 5.03 units and upper 4.32 units respectively with use of ivabradine compared with the use of beta-blockers. These values were statistically significant. Conclusion It seems that the efficacy of ivabradine is good in comparison with betablockers, but it still requires more clinical trials.
机译:背景技术二尖瓣狭窄的患者的心率增加。 HR减少被称为二尖瓣狭窄患者的重要治疗和治疗策略。审查该系统审查和荟萃分析的目的是比较Ivabradine与β-Bet-Beta-Blockers在窦性心律的二尖瓣狭窄患者中的疗效。方法在Cochrane图书馆,Pubmed,Science,CRD,Scopus和Google Scholar中搜索随机控制试验,没有开始时限和截至2018年6月的终止。通过偏见评估工具的Cochrane风险评估偏见的风险。固定效果模型用于将结果和平均差异与95%的置信区间结合起来。使用R软件中的Meta Package进行该元分析。结果五项研究进入META分析。用Ivabradine和Beta-嵌体治疗的患者的总数分别为178和178。结果表明,与使用β-嵌体相比,分别使用Ivabradine分别在约5.03单位和上4.32个单元的最大HR和HR的平均值下降。这些值统计学意义。结论似乎Ivabradine的疗效与Betablockers相比,但仍需要更多的临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号